Track the Clover Health Investments, Corp. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.4bn. The latest transaction was disclosed on 31 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JAMIE REYNOSO. All data is openly available.
20
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Clover Health Investments, Corp. Buy (bullish), based on 3 analysts. Average price target: €5.17.
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,983 of 29,063 companies
22.5
score / 100
Value
27
Quality
19
FCF yld-2.9%
Earn yld-3.1%
EV/EBITDA·
ROE-5.1%
Gross mgn13%
Net mgn-4.4%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
7,289 shares@ US$4.8959.9% of flowCommonSEC144:0001950047-26-005956
20 of 20 declarations
Acerca de Clover Health Investments, Corp.
Clover Health Investments, Corp. es una empresa de tecnología sanitaria que utiliza datos para mejorar la atención al paciente. Se centra en el seguro de salud para personas mayores y poblaciones en riesgo.